Hong Kong · Delayed Price · Currency is HKD Fusen Pharmaceutical Company Company Description
Fusen Pharmaceutical Company Limited, an investment holding company, engages in the manufacturing and sale of pharmaceutical products in the People’s Republic of China.
The company offers Shuanghuanglian oral solutions and injections; Sanhuang tablet; heat-clearing and detoxicating oral solutions; Flunarizine hydrochloride capsules; Sanhuang tablets; compound ferrous sulfate granules; and other pharmaceutical products.
It is also involved in manufacturing and sale of pharmaceutical package materials; research and development of pharmaceutical products; sale of construction materials and pharmaceutical products; and provision of business management and consulting services.
Its medicines are used for the treatment of heat-clearing and detoxification, cardiovascular and cerebrovascular, antihypertensive and hypoglycemic, tonifying, qi-regulating, anti-anemia, and antibacterial and anti-inflammatory.
Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
| Country | Cayman Islands |
| Founded | 2003 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,005 |
| CEO | Zhiming Cao |
Contact Details
Address: Urban Industrial Zone Nanyang China | |
| Website | fusenyy.com |
Stock Details
| Ticker Symbol | 1652 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG370981030 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhiming Cao | Chief Executive Officer and Executive Chairman |
| Taisheng Hou | Executive Director |
| Yongsheng Chi | Executive Director |
| Qingfen Meng | Executive Director |
| Zhen Li | Chief Financial Officer |
| Yuk Hong Yeung | Company Secretary |